OLIPHANT LAURA 4

What Happened
Laura Oliphant, a director of Aehr Test Systems (AEHR), sold a total of 4,546 shares in multiple open-market transactions on January 22, 2026. The sales were: 3,100 shares @ $31.38 ($97,278), 1,026 shares @ $31.44 ($32,257), 180 shares @ $31.45 ($5,661), 100 shares @ $31.46 ($3,146), and 140 shares @ $31.48 ($4,408), for aggregate proceeds of about $142,750. These were outright sales (not purchases, exercises, or gifts), which are commonly routine portfolio-management activity rather than a directional endorsement of the stock.

Key Details

• Transaction date: 2026-01-22 (all trades executed same day)
• Trades and prices:
  • 3,100 shares @ $31.38 — $97,278
  • 1,026 shares @ $31.44 — $32,257
  • 180 shares @ $31.45 — $5,661
  • 100 shares @ $31.46 — $3,146
  • 140 shares @ $31.48 — $4,408
• Total shares sold: 4,546; approximate total proceeds: $142,750
• Shares owned after the transactions: not specified in the provided filing excerpt (see the full Form 4 for the insider’s post-transaction holdings)
• Footnote: F1 notes that the amount reported includes shares subject to unvested restricted stock units (RSUs) — unvested shares can affect reported ownership figures.
• Filing timeliness: Form 4 was filed on 2026-01-26 for trades on 2026-01-22, which is within the typical two-business-day reporting window.

Context: These were open-market sales by a company director. Sales are common for insiders for tax or diversification reasons and do not, by themselves, indicate the insider’s view of the company’s prospects. There were no option exercises, grants, or gifts reported in these transactions. For complete details (post-transaction holdings, certifications, or additional footnotes), review the full SEC Form 4 filing (Accession 0001040470-26-000036).